(Q36731095)

15 August 2017

Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease (English)

1 reference

15 August 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27034879%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Tomoya Miyamura

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27034879%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Eiichi Suematsu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27034879%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

13 March 2016

1 reference

Case reports in rheumatology

15 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27034879%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27034879%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1467583

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27034879%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

2 June 2020

copyright license

start time

1 January 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

Approaches to immunosuppression in Behçet's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

Adalimumab for the treatment of Behçet's disease: experience in 19 patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

Mortality in Behçet's disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

EULAR recommendations for the management of Behçet disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

Life-threatening vasculo-Behçet following discontinuation of infliximab after three years of complete remission.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808526

Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease

5 September 2018

1 reference

12 December 2020

Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab

1 reference

12 December 2020

Cardiovascular prognostic value of vascular involvement in Behcet's disease

1 reference

12 December 2020

Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course

1 reference

12 December 2020

Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis

1 reference

12 December 2020

Identifiers

DOI

10.1155/2016/1467583

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27034879%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27034879%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27034879%20AND%20SRC:MED&resulttype=core&format=json